In our study cohort, we saw that the BCL2L2 gene and the TP53 gene were upregulated in blood from T2DM+DR patients with respect to the CG (see Figure 6) [79,80]. This evidence concerns the gene BCL2L2 and type 2 diabetes mellitus.